Q4 2015 13F Holders as of 12/31/2015
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
157M
-
Number of holders
-
85
-
Total 13F shares, excl. options
-
26.9M
-
Shares change
-
-792K
-
Total reported value, excl. options
-
$321M
-
Value change
-
-$6.21M
-
Put/Call ratio
-
4.15
-
Number of buys
-
48
-
Number of sells
-
-28
-
Price
-
$11.93
Significant Holders of TG THERAPEUTICS, INC. - Common Stock (TGTX) as of Q4 2015
99 filings reported holding TGTX - TG THERAPEUTICS, INC. - Common Stock as of Q4 2015.
TG THERAPEUTICS, INC. - Common Stock (TGTX) has 85 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 26.9M shares
of 157M outstanding shares and own 17.09% of the company stock.
Largest 10 shareholders include FMR LLC (6.26M shares), BRIDGER MANAGEMENT, LLC (3.07M shares), RA CAPITAL MANAGEMENT, LLC (2.81M shares), BAKER BROS. ADVISORS LP (2M shares), UBS ASSET MANAGEMENT AMERICAS INC (1.56M shares), Sectoral Asset Management Inc (1.52M shares), VANGUARD GROUP INC (1.25M shares), STATE STREET CORP (1.14M shares), BlackRock Fund Advisors (959K shares), and BlackRock Institutional Trust Company, N.A. (897K shares).
This table shows the top 85 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.